Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential
Advanced Science · 2025-09 · 12 (33)
DOI: 10.1002/advs.202408397 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 20.06.2025. Verfasst von Fan Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The Medical University of South Carolina, Walton Research Building, Room 403-E, Charleston, SC, 2942…. Hauptthemen laut MEDLINE: Genetic Therapy, Dependovirus, Labyrinth Diseases, Hearing Loss. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 520 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Yunnan Key Laboratory of Children's Major Disease Research.
Abstract (Originalsprache)
Hearing loss imposes a significant global health burden and often results from genetic factors and various external influences, such as noise exposure and the use of ototoxic drugs. Recent advancements in adeno‐associated virus (AAV)‐mediated gene therapy offer promising new avenues for the treatment of inner ear diseases. Clinical trials of AAV‐mediated gene therapies show impressive preliminary results, although further research is needed to evaluate the safety and long‐term effects of these therapies. Preclinical AAV‐mediated gene therapy is notable for its high transduction efficiency and safety. In this article, the development of AAV‐mediated gene therapies is reviewed for inner ear diseases, categorizing these therapies by their strategies for treating hereditary hearing loss, including gene replacement and cluster regularly interspaced short palindromic repeat‐based methods. AAV‐mediated hair cell regeneration therapy is also reviewed for acquired hearing loss, as well as methods to prevent acquired hearing loss. In this article, it is hoped to provide a comprehensive overview of recent progress in AAV‐mediated gene therapy and its future potential, thereby highlighting the importance of this therapy for researchers and clinicians in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, The Medical University of South Carolina, Walton Research Building, Room 403-E, Charleston, SC, 29425, USA.
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510000, China.
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong, 250000, China.
- Department of Otorhinolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China/Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China/…
- Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Yunnan Institute of Pediatrics, Kunming Key Laboratory of Children Infection and Im…
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, Shandong, 250022, China.
ORCID-Profile: Xinyi Pang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Yunnan Key Laboratory of Children's Major Disease Research
- Yunnan Province Clinical Research Center for Children's Health and Disease
- Yunnan International Science and Technology Co-Laboratory of Allergic Disease
- Special Funds for High-level Healthy Talents of Yunnan Province-Medical Leaders
- Medicine-Science and Engineering Interdisciplinary Foundation of Shanghai Hospital Development Center
- School of Medicine, Shanghai Jiao Tong University
Zitieren
APA
Wu, F., He, W., Xiao, Y., Wu, Q., Zhang, Q., Zhang, T., Xu, L., & Pang, X. (2025). Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential. Advanced Science, 12(33). https://doi.org/10.1002/advs.202408397
Vancouver
Wu F, He W, Xiao Y, Wu Q, Zhang Q, Zhang T, et al. Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential. Advanced Science. 2025;12(33). doi:10.1002/advs.202408397
BibTeX
@article{Wu2025,
author = {Wu, Fan and He, Wuhui and Xiao, Yun and Wu, Qiong and Zhang, Qing and Zhang, Tiesong and Xu, Lei and Pang, Xinyi},
title = {Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {33},
doi = {10.1002/advs.202408397}
}
EUVIMED